Title: Palliative Use of Self-expanding Metal Stents in Initially Anticancer Treatment-intolerant
Patients with Esophageal Cancer
Version: 0 Date: 28 May 2024
Reviewer's report:
I applaud the authors for taking on such a difficult patient population to study.  The study looked
at assessing the impact of stent placement in frail EC patients. The overall methodology and
presentation of the paper is very good.  Some questions for consideration:
1. Were there any QOL metrics captured for these patients?
2. 8 of 46 pts had complications. Were there any predictors identified that would link
complications with type of EC ?
3. Have these results changed the center's approach to these patients in particular, and how do
you approach your patients now with this data/ information?
Title: Palliative Use of Self-expanding Metal Stents in Initially Anticancer Treatment-intolerant
Patients with Esophageal Cancer
Version: 0 Date: 28 May 2024
Reviewer's report:
I applaud the authors for taking on such a difficult patient population to study.  The study looked
at assessing the impact of stent placement in frail EC patients. The overall methodology and
presentation of the paper is very good.  Some questions for consideration:
1. Were there any QOL metrics captured for these patients?
2. 8 of 46 pts had complications. Were there any predictors identified that would link
complications with type of EC ?
3. Have these results changed the center's approach to these patients in particular, and how do
you approach your patients now with this data/ information?
Please review this paper.
user
Title: Palliative Use of Self-expanding Metal Stents in Initially Anticancer Treatment-intolerant
Patients with Esophageal Cancer
Version: 0 Date: 28 May 2024
Reviewer's report:
I applaud the authors for taking on such a difficult patient population to study.  The study looked
at assessing the impact of stent placement in frail EC patients. The overall methodology and
presentation of the paper is very good.  Some questions for consideration:
1. Were there any QOL metrics captured for these patients?
2. 8 of 46 pts had complications. Were there any predictors identified that would link
complications with type of EC ?
3. Have these results changed the center's approach to these patients in particular, and how do
you approach your patients now with this data/ information?
assistant